IOL master more accurate in silicone oil-filled eyes

Article

The IOL master is more accurate than A-scan immersion biometry in silicone oil (SO)-filled eyes.

The IOL master is more accurate than A-scan immersion biometry in silicone oil (SO)-filled eyes, claims a study in Eye.

Dr P. Kunavisarut et al., Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, conducted a prospective, consecutive, non-randomized investigation on 34 SO-filled eyes of 34 patients. All patients underwent a pars plana vitrectomy with SO removal and cataract surgery, as well as IOL implantation.

Axial length (AXL) was measured before SO removal using both A-scan immersion and IOL master. AXL was also measured three months after SO removal using IOL master. The accuracy of both techniques was determined by a mean postoperative AXL and reliability was determined by mean actual postoperative refractive error.

The preoperative mean AXL was 23.91±0.24 mm and 23.71±0.59 mm by the IOL master and A-scan immersion, respectively. The IOL master gave a postoperative mean AXL of 23.90±0.23 mm, which was statistically significant, compared with A-scan immersion.

At a range of −14.62 to 16.41 D predictive postoperative refractive error was greater in A-scan immersion, which was a statistically significant difference compared to the IOL master.

Overall, the IOL master is more accurate and has less deviation in predictive postoperative refractive error then A-scan immersion in SO-filled eyes.

The abstract can be read here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.